Nyxoah SA Form 6-K Summary
Business context and reporting period
Nyxoah SA furnished a Form 6-K for September 2026, filed September 22, 2026. The filing reports a senior management change and includes a related September 21, 2026 press release as Exhibit 99.1. It does not provide operating or financial results for a reporting period.
Key financial metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Material changes versus the prior comparable period
- John Landry will step down as Chief Financial Officer effective October 2, 2026.
- Loic Moreau, currently President International and a former Nyxoah CFO, will become Interim Chief Financial Officer effective October 2, 2026.
- Mr. Moreau previously served as CFO from January 2022 through November 2024 and has held senior finance and corporate development roles at GlaxoSmithKline, Ernst & Young, and PricewaterhouseCoopers.
Guidance, outlook, risks, contingencies, and unusual items
The filing provides no financial guidance or operating outlook. The CFO transition is the principal unusual item disclosed. The filing does not state the reason for Mr. Landry’s departure, identify a permanent CFO search process, or describe any expected impact on financial reporting, strategy, or operations.
Investor verification points
- Verify the effective date of the transition: October 2, 2026.
- Assess whether Nyxoah appoints a permanent CFO and whether additional management changes follow.
- Review subsequent filings for any effect on financial reporting, internal controls, liquidity, or strategic execution.
- Note that Exhibit 99.1 is furnished rather than filed for purposes of Section 18 of the Exchange Act and is not incorporated by reference except where expressly stated.